Head of Corporate Public Affairs Europe for Sanofi, leading a team in charge of driving Sanofi engagement across Europe - EU institutions and EU/country stakeholders - on policy and legislative topics related to healthcare incl. health innovation, health care system sustainability, access & procurement, pandemic response & preparedness, healthcare, supply & industrial strategy, digital health/AI, climate & health and pharma regulations.

She is the President of Vaccines Europe Board since September 2022 and co-chair of the Vaccines Europe/EFPIA biopreparedness taskforce leading industry interactions with EU Commission DG HERA. She has been active in trade associations for more than 10 years, in particular by contributing to COVID-19 vaccine access, EU Joint Action on Vaccination, influenza and adult immunisation, sustainable supply and HTA topics.

Over her 20+ year career, she occupied various positions from health economics & outcome research to market access / HTA and policy affairs in Europe, in consulting companies and Sanofi Pasteur-MSD, before joining Sanofi in 2017. She has an extensive knowledge of the vaccines business and European policies.

Education: Doctor in Pharmacy and post-graduate degree in health economics and business from EMLyon Business School.